Health4 hours ago
Moderna Reports Significant Boost in Antibodies for Redesigned COVID Vaccine
Moderna has released updated data from a Phase 4 clinical trial demonstrating that its redesigned COVID-19 vaccine, known as mNEXSPIKE, significantly enhances immune response. The study...
